Recombinant Human PLIN Protein，GST

PLIN (Perilipin) proteins are a family of lipid droplet-associated proteins that play crucial roles in regulating lipid metabolism, particularly in adipocytes and other lipid-storing cells. Research on PLIN proteins has gained momentum due to their involvement in obesity, insulin resistance, and metabolic disorders. The PLIN family consists of several members, including PLIN1, PLIN2, PLIN3, PLIN4, and PLIN5, each exhibiting distinct regulatory functions in lipid storage and mobilization. PLIN1, for instance, is predominantly expressed in adipose tissues and is integral to lipolysis regulation, while PLIN2 is widely distributed in various tissues and serves as a protective factor against lipotoxicity. Investigating the structure and function of PLIN proteins, particularly through recombinant technology, has facilitated a deeper understanding of their roles in cellular lipid dynamics. Recombinant PLIN proteins enable researchers to explore their interactions with other cellular components, such as enzymes involved in lipid metabolism, and to elucidate the mechanisms underlying their regulatory functions. This has significant implications for developing therapeutic strategies targeting metabolic diseases. Current studies also focus on the post-translational modifications and signaling pathways associated with PLIN proteins, which are critical for understanding their actions in health and disease. Overall, the study of PLIN recombinant proteins represents a promising avenue for advancing our knowledge of lipid biology and its connections to various health conditions, paving the way for innovative treatments against obesity and related metabolic disorders.